Quantcast
Parents Perceive Using Agave Nectar Placebo Are Better Than

Parents Perceive Using Agave Nectar, Placebo Are Better Than Doing Nothing For Cough In Kids

Provided by The JAMA Network Journals Pasteurized agave nectar and placebo were both perceived to be better by parents for treating nighttime cough and the resulting sleep difficulty in infants and toddlers than doing nothing at all, according...

Latest placebo Stories

2014-10-30 04:21:00

LUGANO, Switzerland, October 30, 2014 /PRNewswire/ -- In ROMANA 1, a pivotal Phase III study, anamorelin was shown to increase lean body mass and body weight, reduce fatigue and improve health-related quality of life in patients with advanced NSCLC cachexia. Helsinn Group, the Company focused on building quality cancer care, announces that anamorelin, its investigational novel once-daily ghrelin receptor agonist for the treatment of cancer anorexia-cachexia syndrome...

2014-10-29 16:28:45

REHOVOT, Israel, October 29, 2014 /PRNewswire/ -- Company also reports encouraging partial results from Phase IIa study of continuous, subcutaneously delivered high-dose liquid levodopa/carbidopa (ND0612H) therapy for advanced patients Data presented at the Michael J. Fox Foundation 2014 Parkinson's Disease Therapeutics Conference NeuroDerm Ltd., a clinical-stage pharmaceutical...

2014-10-27 16:29:02

BOSTON, Oct. 27, 2014 /PRNewswire/ -- Shares in Alcobra Ltd ("Alcobra" or the "Company") (NASDAQ: ADHD) dropped 60% on October 6, 2014 after disclosing the results of the Phase III study of MDX (an experimental formulation of vitamin B6) which showed that the drug failed to improve ADHD symptoms compared to a placebo. An even greater stock drop was averted, however, when Alcobra issued a press release the same day announcing that an alternative analysis of the Phase III study...

2014-10-24 08:26:10

BOSTON, Oct. 24, 2014 /PRNewswire/ -- Rhythm announced today the presentation of results from a Phase 2a clinical trial assessing the safety and efficacy of relamorelin (RM-131) in 48 patients with chronic constipation. Analysis of the data indicates that relamorelin administered once daily for two weeks in patients with chronic constipation significantly improves constipation symptoms, along with accelerating colonic transit. The study results were presented in a late-breaker session at the...

2014-10-22 08:31:01

Results indicate Zalviso controlled moderate-to-severe acute pain following abdominal surgery better than placebo, with similar side effect profile REDWOOD CITY, Calif., Oct. 22, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) today announced that results from the IAP310 study have been published in Regional Anesthesia and Pain Medicine (RAPM), a peer-reviewed journal with broad, multidisciplinary readership. IAP310 was a randomized, placebo-controlled, Phase 3...

2014-10-15 20:22:42

Company to make OFEV available to IPF community within 10 days, along with comprehensive patient support resources RIDGEFIELD, Conn., Oct. 15, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved OFEV® (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF). Granted Breakthrough Therapy designation during its review by the FDA, OFEV, capsules for oral use, taken twice...

2014-10-14 08:33:40

MIAMI and NEW YORK, Oct. 14, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc., today announced the publication of data on the effects of low-dose mesylate salt of paroxetine (LDMP), marketed as Brisdelle(® )(paroxetine) capsules, 7.5 mg, in the October 2014 issue of Menopause, the peer-reviewed, scientific journal of The North American Menopause Society (NAMS). The article, "Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated...

2014-10-13 16:25:04

--Study Demonstrated Clinically Meaningful and Statistically Significant Improvement of Agitation in Patients with Alzheimer's Disease-- ALISO VIEJO, Calif., Oct. 13, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that results from the Phase II study evaluating AVP-923 for the treatment of agitation in patients with Alzheimer's disease were presented at the 2014 American Neurological Association Meeting. In this study utilizing the two-stage, sequential...

2014-10-10 12:24:47

WOODCLIFF LAKE, N.J. and SAN DIEGO, Oct. 10, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that a pooled analysis of the BLOOM and BLOSSOM pivotal, Phase 3 clinical trials of BELVIQ(®) (lorcaserin HCl) was published in the October issue of Postgraduate Medicine, a peer-reviewed medical journal for physicians. In the pooled analysis, BELVIQ 10 mg twice daily, as compared to placebo and both in conjunction with diet and exercise, was associated...

2014-10-08 16:26:39

Research conducted on slaughterhouse workers with chronic pain symptoms. AKRON, Ohio, Oct. 8, 2014 /PRNewswire/ -- Researchers at the National Research Centre for the Working Environment in Copenhagen, Denmark compared the effectiveness of Biofreeze(®) topical analgesic and a placebo gel on reducing chronic pain and symptoms of carpal tunnel syndrome in slaughterhouse workers. Compared to the placebo gel, Biofreeze Pain Reliever reduced hand/wrist pain by 31%. Carpal tunnel...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related